Hasan M Isa1, Afaf M Mohamed2, Halima E Al-Jowder1, Khadija A Matrook1, Haya H Althawadi3. 1. Pediatric Department, Salmaniya Medical Complex, Arabian Gulf University, Manama, Bahrain. 2. Consultant Family physician, Shaikh Jaber Health Centre, Manama, Bahrain. 3. Pediatric Department, Arabian Gulf University, Manama, Bahrain.
Abstract
OBJECTIVES: Our study aimed to report the epidemiology, clinical presentations, diagnostic and therapeutic approaches, and outcomes of Crohn's disease (CD) in pediatric patients in Bahrain. METHODS: We conducted a retrospective review of the medical records of patients with CD diagnosed in the pediatric department, Salmaniya Medical Complex, Bahrain, between 1984 and 2017. We used the data to calculate the annual incidence and cumulative prevalence. Data about gender, nationality, clinical presentation, age at presentation and diagnosis, duration of illness, consanguinity, family history, contact with smokers, and comorbidities were gathered. Results of hematological, biochemical, and serological tests were also collected. All radiological, endoscopic, and histopathological findings were reviewed. Data about medical therapy, relapse episodes, hospital admissions, complications, and outcomes were collected. RESULTS: Of 108 pediatric patients diagnosed with inflammatory bowel disease (IBD), 51 (47.2%) patients had CD. The annual incidence was 1 in 100 000 per year (range = 0-5 patients/year) with significant rise on comparing the three decades (p = 0.0001). Prevalence was 9.32 patients per 100 000 pediatric populations. Thirty-four patients (66.7%) were males, and the median age was 18.5 years (range = 6.4-35.0). Common clinical presentations were recurrent abdominal pain and weight loss. Family history of IBD was found in 10 patients. One patient had positive antineutrophil cytoplasmic antibody. The terminal ileum was involved in 68.1%, colon in 63.8%, and perianal area in 17.0% patients. Biological therapy was used in five patients. Surgical intervention was required in six patients. The mean follow-up period was 9.2±5.6 years. CONCLUSIONS: The clinical characteristics of our population are comparable to that reported in neighboring countries and worldwide.
OBJECTIVES: Our study aimed to report the epidemiology, clinical presentations, diagnostic and therapeutic approaches, and outcomes of Crohn's disease (CD) in pediatric patients in Bahrain. METHODS: We conducted a retrospective review of the medical records of patients with CD diagnosed in the pediatric department, Salmaniya Medical Complex, Bahrain, between 1984 and 2017. We used the data to calculate the annual incidence and cumulative prevalence. Data about gender, nationality, clinical presentation, age at presentation and diagnosis, duration of illness, consanguinity, family history, contact with smokers, and comorbidities were gathered. Results of hematological, biochemical, and serological tests were also collected. All radiological, endoscopic, and histopathological findings were reviewed. Data about medical therapy, relapse episodes, hospital admissions, complications, and outcomes were collected. RESULTS: Of 108 pediatric patients diagnosed with inflammatory bowel disease (IBD), 51 (47.2%) patients had CD. The annual incidence was 1 in 100 000 per year (range = 0-5 patients/year) with significant rise on comparing the three decades (p = 0.0001). Prevalence was 9.32 patients per 100 000 pediatric populations. Thirty-four patients (66.7%) were males, and the median age was 18.5 years (range = 6.4-35.0). Common clinical presentations were recurrent abdominal pain and weight loss. Family history of IBD was found in 10 patients. One patient had positive antineutrophil cytoplasmic antibody. The terminal ileum was involved in 68.1%, colon in 63.8%, and perianal area in 17.0% patients. Biological therapy was used in five patients. Surgical intervention was required in six patients. The mean follow-up period was 9.2±5.6 years. CONCLUSIONS: The clinical characteristics of our population are comparable to that reported in neighboring countries and worldwide.
Authors: Mohammad I El Mouzan; Omar Saadah; Khalid Al-Saleem; Mohammad Al Edreesi; Mohammed Hasosah; Aziz Alanazi; Mohammad Al Mofarreh; Ali Asery; Abdulaziz Al Qourain; Khaled Nouli; Abdulrahman Al Hussaini; Abdulwahab Telmesani; Khalid AlReheili; Sharifa Alghamdi; Nawal Alrobiaa; Abdullah Alzaben; Ahmad Mehmadi; Homoud Al Hebbi; Ahmad Al Sarkhy; Ali Al Mehaidib; Badr Al Saleem; Asaad Assiri; Sami Wali Journal: Inflamm Bowel Dis Date: 2014-06 Impact factor: 5.325
Authors: Athos Bousvaros; Donald A Antonioli; Richard B Colletti; Marla C Dubinsky; Jonathan N Glickman; Benjamin D Gold; Anne M Griffiths; Gareth P Jevon; Leslie M Higuchi; Jeffrey S Hyams; Barbara S Kirschner; Subra Kugathasan; Robert N Baldassano; Pierre A Russo Journal: J Pediatr Gastroenterol Nutr Date: 2007-05 Impact factor: 2.839
Authors: Wafa'a A Al-Qabandi; Eman K Buhamrah; Khaled A Hamadi; Suad A Al-Osaimi; Ahlam A Al-Ruwayeh; JohnPatrick Madda Journal: Saudi J Gastroenterol Date: 2011 Sep-Oct Impact factor: 2.485
Authors: Omar I Saadah; Mohammad El Mouzan; Mohammad Al Mofarreh; Ali Al Mehaidib; Mohammad Al Edreesi; Mohammed Hasosah; Abdulrahman Al-Hussaini; Khalid AlSaleem Journal: Gastroenterol Res Pract Date: 2015-12-29 Impact factor: 2.260
Authors: Mohammad I El Mouzan; Mohammed H AlEdreesi; Mohammed Y Hasosah; Abdulrahman A Al-Hussaini; Ahmad A Al Sarkhy; Asaad A Assiri Journal: World J Gastroenterol Date: 2020-01-28 Impact factor: 5.742